Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-02-000371
Filing Date
2002-02-19
Accepted
2002-02-19 00:00:00
Documents
1
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sch13g_021402.txt SC 13G 11493
  Complete submission text file 0000947871-02-000371.txt   13532
Mailing Address 103 CARNEGIE CENTER, SUITE 200 SUITE 100 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER, SUITE 200 SUITE 100 PRINCETON NJ 08540 609-520-1911
PALATIN TECHNOLOGIES INC (Subject) CIK: 0000911216 (see all company filings)

EIN.: 954078884 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-45766 | Film No.: 02552368
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE